000			04245cam a2200409M 4500
999			_c9660 _d9660
001			9660
003			ES-VaUE
005			20210514161246.0
006			m o d
007			cr |n|||||||||
008			201031s2020 xx o 0|| 0 eng d
017			_a1204142059
020			_a9783030525552 ( _q) ( _qelectronic bk.)
020			_a3030525554 ( _q) ( _qelectronic bk.)
020			_z3030525546
020			_z9783030525545
024	1		_aAU@ _b000068176377
040			_aYDX _beng _cYDX _dEBLCP _dUKAHL
050			_aRG732 _b.K36 2021 EB
245	0	0	_aSedation and Analgesia for the Pediatric Intensivist: _ba clinical guide _cPradip P. Kamat, John W. Berkenbosch
250			_a1st ed. 2021
260			_aCham _bSpringer _c2021
300			_a1 online resource
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
505	0		_aIntro -- Foreword -- Preface -- Contents -- Contributors -- Part I: Sedation and Analgesia for the Critically Ill Child -- Chapter 1: Introduction to Sedation and Analgesia -- Brief History of Pediatric Sedation and Analgesia -- Goal of Sedation and Analgesia in the Critically Ill Child -- Physiology of Pain -- Complexities of Sedation and Analgesia in the Critically Ill Child -- References -- Chapter 2: Safety and Monitoring During Pediatric ICU Sedation -- Assessment Tools -- Pain Assessment -- Self-Report Tools and Surrogate Reporting -- Observational Tools
505	8		_aAgitation and Sedation Assessment -- Objective Monitoring Tools -- Processed EEG -- Conventional EEG -- Conclusions -- References -- Chapter 3: Analgesic Use in the Pediatric Intensive Care Unit -- Specific Agents -- References -- Chapter 4: Regional Analgesia and Its Role in the PICU -- Introduction -- History -- Safety and Risks of Regional Anesthesia -- Benefits of Regional Anesthesia -- Some Common Blocks -- Central Neuraxial Blocks -- Upper Extremity Blocks -- Truncal Blocks -- Lower Extremity Blocks -- Conclusion -- References -- Part II: Sedative Agents
505	8		_aChapter 5: Sedative Agents (Benzodiazepines) -- Overview of Benzodiazepines and Mechanism of Action -- Pharmacokinetic and Pharmacodynamic Considerations -- Adverse Reactions, Drug-Drug Interactions, and Monitoring Parameters -- Benzodiazepine and Opioids -- Breastfeeding/Pregnancy Considerations -- Pregnancy Considerations -- Breastfeeding Considerations -- In Summary -- References -- Chapter 6: Alpha-Agonists in Pediatric Critical Care -- Introduction -- Pharmacology -- Clinical Applications -- Conclusion -- References -- Chapter 7: Barbiturates in the Pediatric ICU -- Introduction
505	8		_aPharmacology -- Clinical Applications -- References -- Part III: Anesthetic Agents -- Chapter 8: Sedation and Analgesia for the Critically Ill Child: Ketamine -- Introduction -- Pharmacokinetics and Pharmacodynamics -- Mechanism of Action -- Dosing -- Uses of Ketamine in the Pediatric Intensive Care Unit -- Ketamine for Sedation -- Ketamine for Acute Pain -- Ketamine for Chronic Pain -- Ketamine Side Effects -- Conclusion -- References -- Chapter 9: Propofol for Sedation of the Critically Ill Child -- Introduction -- Pharmacology -- Mechanism of Action -- Pharmacokinetics -- Pharmacodynamics
505	8		_aClinical Considerations for Use -- Indications for Short-Term, Deep Sedation -- Propofol "Drug Washout" -- The Impact of Propofol on Sleep and Delirium in ICU Patients -- Palliative Sedation -- Propofol-Related Infusion Syndrome (PRIS) -- Pathophysiology -- Prevention and Treatment -- Consideration in Special Populations -- Mitochondrial and Metabolic Disorders -- Conclusions -- Bibliography -- Chapter 10: Inhalational Agents: What Volatile Inhalational Agents Are and How to Use Them in the ICU Setting -- Introduction -- Principles of Inhalational Agents -- Minimum Alveolar Concentration
655		0	_aElectronic books
776	0	8	_cOriginal _z3030525546 _z9783030525545 _w(OCoLC)1156994402
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/http://doi.org/10.1007/978-3-030-52555-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db